title: A study on comparative efficacyof hypolipidemic drugs.
abstract: A study was carried out on the comparative efficacy of Lopid, Mevacor, Bezalip and Lasona in sixteen hyperlipidemic subjects. All the subjects were on Lopid at least for the last 15 days. Lopid therapy was discontinued after determining blood lipid profile of the subjects on day zero (day of 1st contact). The subjects were divided into three groups and after a washout period of 15 days, they were given three different drugs for the next 15 days. Subjects in group a (6), b (5) and c (5) received Mevacor, Bezalip and lasona respectively. In the present study mevacor was found to be the most potent hypolipidemic drug in lowering blood cholesterol and Low density lipoprotein (LDL) while lopid was most effective in keeping blood Triglycerides (TG) and High density lipoproteins (HDL) level within the desired limits. Bezalip and Lasona were also sufficiently effective in changing blood lipid profile, but lasona showed a negligible effect on HDL rise as compared with Bezalip or any other drug used in this study.
authors.affiliation: Department of Basic Medical Sciences, Faculty of Pharmacy, Gomal University, Dera Ismail Khan.
authors.forename: A
authors.initials: A
authors.lastname: Sher
authors.forename: A
authors.initials: A
authors.lastname: Ullah
authors.forename: A
authors.initials: A
authors.lastname: Mateen